Spruce Biosciences, Inc. (SPRB) income statement
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.40+0.75 (+1.89%)
Close on Oct 19, 2026Market cap $98.22MP/E –Yield –
Spruce Biosciences, Inc. financial ratios
See a number that looks wrong?